While the rate of late-stage NSCLC diagnosis is improving, more needs to be done to increase survival rates. Are there outside factors that affect the stage at diagnosis, and what can we learn from them?
A survey revealed a lack of racial, ethnic, and gender diversity in leadership positions at US cancer centers.
Black race was associated with lower rates of biochemical relapse, distant metastases, and prostate cancer-specific mortality.
Researchers found a “strong genetic basis” for racial differences in survival.
Only 3% of medical oncologists in the United States are Black.
How significant is the racial disparity in treating patients with skin cancer? Studies in recent years that suggest a troubling difference in the diagnosis and treatment some patients receive. We explore the significant impact this has on patient prognosis.
Investigators used next-generation sequencing to characterize the genomic profile of squamous cell carcinoma (SCC) in 26 Colombian patients with lung SCC.
How effective is surgical treatment for ductal carcinoma in situ (DCIS) at preventing an invasive recurrence of breast cancer? Treatment is intended to significantly lessen the lifetime risk of breast cancer and breast cancer-related mortality, but are patients diagnosed with DCIS still at risk for experiencing poor outcomes? A recent study in JAMA Network Open…
A significant amount of progress has been made in improving the treatment of lung cancer and patient outcomes. However, a number of disparities that can have an impact on these persist, including those affecting lung cancer screening. Lung cancer screening is an essential step toward effective treatment and improved survival, but its success depends on…
Efforts should be made to address patient concerns about clinical trial participation.
